Dr. Ronald G. Nahass, President of the Infectious Diseases Society of America (IDSA) and interim CEO and President of ID Care, recently offered perspective on the ongoing debate between medical professionals and federal health officials over changes to vaccine recommendations.
With a federal advisory panel convened by the Department of Health and Human Services debating adjustments to longstanding childhood vaccine policy—including proposed changes to the routine newborn hepatitis B vaccination—leading physician groups have voiced concern. In remarks to the press, Dr. Nahass underscored the importance of evidence-based recommendations and consistent messaging, noting that sudden shifts without clear scientific justification can create uncertainty for families and clinicians.
“We owe our patients a consistent message informed by evidence and lived experience,” Dr. Nahass said, emphasizing that trusted clinical guidance is vital as parents navigate complex decisions about immunizations.
As national dialogue continues around vaccine policy, Dr. Nahass remains a strong advocate for collaboration across medical organizations and for clear communication grounded in rigorous science.
Read the full coverage in KSAT Health